Device
Overview
Teva markets a number of devices. A medical device does not require the approval of a licence (SmPC) in the same way as a pharmaceutical drug does, therefore there will not be any documentation attached to this product on our website. To contact Teva's Medical Information Service email: medinfo@tevauk.com or telephone: 0207 540 7117.
- Device
- Ointment
Date of preparation: April 2023
D: COB-GB-NP-00112 (V1.0) / T: COB-GB-NP-00102 (V1.0) / M: COB-GB-NP-00103 (V1.0)
Date of preparation: April 2023
D: COB-GB-00016 (V1.0) / T: COB-GB-00014 (V1.0) / M: COB-GB-00015 (V1.0)
Date of preparation: April 2023
D: COB-GB-NP-00104 (V1.0) / T: COB-GB-NP-00105 (V1.0) / M: COB-GB-NP-00106 (V1.0)